Tactile Systems Technology Inc (TCMD) stock
TCMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q/A on Nov 3, 2026Score 17/301% below fair value
$26.05−0.32 (-1.21%)
Close on Nov 17, 2026Market cap $590.09MP/E 25.3Yield –
Tactile Systems Technology r&d expenses
Research and development expenses are spending on new products and technology.
Tactile Systems Technology's R&D Expenses for the twelve months ending Sep 30, 2026 was $10.31M, up 29.1% year over year. For fiscal 2025 it was $8.48M, down 4.0% from the year before. Over ten years it grew 7.0% a year on average. The highest annual figure on record is $8.83M in fiscal 2024.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.48M | -4.0% |
| FY2024 | Dec 31, 2024 | $8.83M | +12.9% |
| FY2023 | Dec 31, 2023 | $7.82M | +10.4% |
| FY2022 | Dec 31, 2022 | $7.09M | +25.3% |
| FY2021 | Dec 31, 2021 | $5.66M | +7.5% |
| FY2020 | Dec 31, 2020 | $5.26M | +1.7% |
| FY2019 | Dec 31, 2019 | $5.17M | -2.2% |
| FY2018 | Dec 31, 2018 | $5.29M | +4.5% |
| FY2017 | Dec 31, 2017 | $5.06M | +13.0% |
| FY2016 | Dec 31, 2016 | $4.48M | +3.8% |
| FY2015 | Dec 31, 2015 | $4.31M | +51.7% |
| FY2014 | Dec 31, 2014 | $2.84M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $2.51M | +14.4% |
| Q2 FY2026 | Jun 30, 2026 | $2.50M | +23.9% |
| Q1 FY2026 | Mar 31, 2026 | $2.78M | +59.4% |
| Q4 FY2025 | Dec 31, 2025 | $2.53M | +24.2% |
| Q3 FY2025 | Sep 30, 2025 | $2.19M | -9.4% |
| Q2 FY2025 | Jun 30, 2025 | $2.02M | -9.7% |
| Q1 FY2025 | Mar 31, 2025 | $1.74M | -18.8% |
| Q4 FY2024 | Dec 31, 2024 | $2.04M | +13.7% |
| Q3 FY2024 | Sep 30, 2024 | $2.42M | +23.1% |
| Q2 FY2024 | Jun 30, 2024 | $2.23M | +21.9% |
| Q1 FY2024 | Mar 31, 2024 | $2.14M | -4.0% |
| Q4 FY2023 | Dec 31, 2023 | $1.79M | -16.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.96M | +24.2% |
| Q2 FY2023 | Jun 30, 2023 | $1.83M | -0.9% |
| Q1 FY2023 | Mar 31, 2023 | $2.23M | +46.9% |
| Q4 FY2022 | Dec 31, 2022 | $2.14M | +20.6% |
| Q3 FY2022 | Sep 30, 2022 | $1.58M | +12.2% |
| Q2 FY2022 | Jun 30, 2022 | $1.85M | +53.3% |
| Q1 FY2022 | Mar 31, 2022 | $1.52M | +19.7% |
| Q4 FY2021 | Dec 31, 2021 | $1.77M | +29.2% |
| Q3 FY2021 | Sep 30, 2021 | $1.41M | +27.9% |
| Q2 FY2021 | Jun 30, 2021 | $1.21M | +9.1% |
| Q1 FY2021 | Mar 31, 2021 | $1.27M | -24.6% |
| Q4 FY2020 | Dec 31, 2020 | $1.37M | +15.2% |
| Q3 FY2020 | Sep 30, 2020 | $1.10M | -24.9% |
| Q2 FY2020 | Jun 30, 2020 | $1.11M | -10.5% |
| Q1 FY2020 | Mar 31, 2020 | $1.68M | +31.5% |
| Q4 FY2019 | Dec 31, 2019 | $1.19M | -11.0% |
| Q3 FY2019 | Sep 30, 2019 | $1.47M | +20.0% |
| Q2 FY2019 | Jun 30, 2019 | $1.23M | -4.3% |
| Q1 FY2019 | Mar 31, 2019 | $1.28M | -10.9% |
| Q4 FY2018 | Dec 31, 2018 | $1.34M | -1.5% |
| Q3 FY2018 | Sep 30, 2018 | $1.22M | +9.6% |
| Q2 FY2018 | Jun 30, 2018 | $1.29M | -12.0% |
| Q1 FY2018 | Mar 31, 2018 | $1.44M | +28.5% |
| Q4 FY2017 | Dec 31, 2017 | $1.36M | +17.1% |
| Q3 FY2017 | Sep 30, 2017 | $1.12M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.47M | – |
| Q1 FY2017 | Mar 31, 2017 | $1.12M | – |
| Q4 FY2016 | Dec 31, 2016 | $1.16M | – |
See a number that looks wrong?